2024 HCPCS Code Q5117
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
| Short Description | Inj., kanjinti, 10 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | October 01, 2019 |
| HCPCS Code Added Date | October 01, 2019 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q9964 - Hocm>= 400mg/ml iodine, 1ml
- Q9965 - Locm 100-199mg/ml iodine,1ml
- Q9966 - Locm 200-299mg/ml iodine,1ml
- Q9967 - Locm 300-399mg/ml iodine,1ml
- Q9968 - Visualization adjunct
- Q9969 - Non-heu tc-99m add-on/dose
- Q9970 - Inj ferric carboxymaltos 1mg
- Q9972 - Epoetin beta esrd use
- Q9973 - Epoetin beta non esrd
- Q9974 - Morphine epidural/intratheca
- Q9975 - Factor viii fc fusion recomb
- Q9976 - Inj ferric pyrophosphate cit
- Q9977 - Compounded drug noc
- Q9978 - Netupitant palonosetron oral
- Q9979 - Injection, alemtuzumab
- Q9980 - Genvisc, inj, 1mg
- Q9981 - Rolapitant, oral, 1mg
- Q9982 - Flutemetamol f18 diagnostic
- Q9983 - Florbetaben f18 diagnostic
- Q9984 - Kyleena, 19.5 mg